CAS 1643672-70-1

Frovocimab

CAS: 1643672-70-1

Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody targeting PCSK9 that binds to the catalytic domain of PCSK9.

Reinheit: 97.4% (SDS-PAGE); 95.3% (SEC-HPLC) - 97.4% (SDS-PAGE); 95.3% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 146.38 kDa

Ref: TM-T77014

Frovocimab

CAS: 1643672-70-1

A humanized IgG4 monoclonal antibody that neutralizes PCSK9.

Ref: 3D-CLA1531